PMV Pharmaceuticals, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
PMV Pharmaceuticals, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2019 to Q4 2023.
  • PMV Pharmaceuticals, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $93.8M, a 25.2% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $93.8M +$18.9M +25.2% Dec 31, 2023 10-K 2024-02-29
Q4 2022 $74.9M +$22.2M +42.1% Dec 31, 2022 10-K 2024-02-29
Q4 2021 $52.7M +$21.3M +67.6% Dec 31, 2021 10-K 2023-03-01
Q4 2020 $31.5M +$10.4M +49% Dec 31, 2020 10-K 2022-03-01
Q4 2019 $21.1M Dec 31, 2019 10-K 2021-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.